This is a preview of subscription content, log in via an institution to check access.
References and Further Readings
Cáceda, R., Kinkead, B., & Nemeroff, C. B. (2006). Neurotensin: Role in psychiatric and neurological diseases. Peptides, 27, 2385–2404.
Dupouy, S., Mourra, N., Doan, V. K., Gompel, A., Alifano, M., & Forgez, P. (2011). The potential use of the neurotensin high affinity receptor 1 as a biomarker for cancer progression and as a component of personalized medicine in selective cancers. Biochimie, 93, 1369–1378.
Mustain, W. C., Rychahou, P. G., & Evers, B. M. (2011). The role of neurotensin in physiologic and pathologic processes. Current Opinion in Endocrinology, Diabetes, and Obesity, 18, 75–82.
Pang, X., Alexacos, N., Letourneau, R., Seretakis D, D., Gao, W., Boucher, W., Cochrane, D. E., & Theoharides, T. C. (1998). A neurotensin receptor antagonist inhibits acute immobilization stress-induced cardiac mast cell degranulation, a corticotropin-releasing hormone-dependent process. Journal of Pharmacology and Experimental Therapy, 287, 307–314.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this entry
Cite this entry
Gidron, Y. (2016). Neurotensin. In: Gellman, M., Turner, J. (eds) Encyclopedia of Behavioral Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6439-6_1461-2
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6439-6_1461-2
Received:
Accepted:
Published:
Publisher Name: Springer, New York, NY
Online ISBN: 978-1-4614-6439-6
eBook Packages: Springer Reference MedicineReference Module Medicine